Skip to main content
Market intelligence
CRBPHealthcare

Corbus Pharmaceuticals Holdings Inc insider activity

In the last 90 days, 1 corporate insider purchased $126,255 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$126,255
Corporate buyers
1
Latest transaction
Aug 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 11, 2026Nishant C SaxenaChief Business OfficerOpen Market Purchase2,600$9.63$25,036
Aug 7, 2026Yuval CohenChief Executive OfficerSale17,000$10.08$171,396
Aug 7, 2026Sean F. MoranChief Financial OfficerSale12,000$10.08$120,971